These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 11220661)
1. Exposure biomarkers in chemoprevention studies of liver cancer. Wild CP; Turner PC IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661 [TBL] [Abstract][Full Text] [Related]
2. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Groopman JD; Wang JS; Scholl P Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033 [TBL] [Abstract][Full Text] [Related]
3. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933 [TBL] [Abstract][Full Text] [Related]
4. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273 [TBL] [Abstract][Full Text] [Related]
6. Role of metabolism and viruses in aflatoxin-induced liver cancer. Groopman JD; Kensler TW Toxicol Appl Pharmacol; 2005 Aug; 206(2):131-7. PubMed ID: 15967201 [TBL] [Abstract][Full Text] [Related]
7. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Wild CP; Hudson GJ; Sabbioni G; Chapot B; Hall AJ; Wogan GN; Whittle H; Montesano R; Groopman JD Cancer Epidemiol Biomarkers Prev; 1992; 1(3):229-34. PubMed ID: 1339083 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand. Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961 [TBL] [Abstract][Full Text] [Related]
9. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587 [TBL] [Abstract][Full Text] [Related]
10. Impacts of chemicals on liver cancer risk. Wogan GN Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069 [TBL] [Abstract][Full Text] [Related]
11. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China. Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907 [TBL] [Abstract][Full Text] [Related]
12. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Hussain SP; Schwank J; Staib F; Wang XW; Harris CC Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772 [TBL] [Abstract][Full Text] [Related]
14. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials. Kensler TW; Groopman JD J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911 [TBL] [Abstract][Full Text] [Related]
16. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure. Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461 [TBL] [Abstract][Full Text] [Related]
17. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Wild CP; Montesano R Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001 [TBL] [Abstract][Full Text] [Related]
18. Aflatoxin and liver cancer. Jackson PE; Groopman JD Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of malignant liver tumors]. Rodella S; Picoco C Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428 [TBL] [Abstract][Full Text] [Related]
20. Prevention of hepatocellular carcinoma in nonviral-related liver diseases. Fan JG; Farrell GC; J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]